Eli Lilly
The pharmaceutical giant was founded in Indianapolis in 1876. It introduced the world's first commercially available insulin product, Iletin, in 1923 for the treatment of diabetes. It was also the first company to manufacture and globally distribute Jonas Salk's polio vaccine. Today Lilly is known best for clinical depression drugs Prozac (1986) and Cymbalta (2004) and antipsychotic medication Zyprexa (1996), though its biggest revenue drivers are diabetes drugs Trulicity (2014) and Humalog (1996). Still headquartered in Indiana's capital city, the company made its largest acquisition ever in 2019 when it purchased Stamford, Conn.'s Loxo Oncology for $8 billion.
Michael Conroy—AP Images
Company Information
As of 6/5/23
Country
U.S.
Headquarters
Indianapolis
Industry
Pharmaceuticals
CEO
David A. Ricks
Website
Company Type
Public
Ticker
LLY
Revenues ($M)
$28,541
Profits ($M)
$6,245
Market Value ($M)
$326,351
Employees
39,000
Market value as of March 31, 2023.
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)
6.90
EPS % Change (from 2021)
12.7%
EPS % Change (5 year annual rate)
-
EPS % Change (10 year annual rate)
6.5%
Total Return
Total Return to Investors (2022)
34.1%
Total Return to Investors (5 year, annualized)
36.6%
Total Return to Investors (10 year, annualized)
25.1%
World's Most Admired Companies
Sector
Natural resources
Industry
Pharmaceuticals
Current All-Star Rank
-
Previous All-Star Rank
-
Industry Rank
5
Previous Industry Rank
8
Overall Score
7.29
Innovation
6
People Management
5
Use of Corporate Assets
4
Social Responsibility
6
Quality of Management
4
Financial Soundness
8
Long-Term Investment Value
4
Quality of Products/Services
5
Global Competitiveness
9
Key Financials (Last Fiscal Year)
($ Millions)
% change
Revenues ($M)
$24,539.8
9.9%
Profits ($M)
$6,193.7
-25.5%
Assets ($M)
$46,633.1
-
Total Stockholder Equity ($M)
$5,641.6
-
Profit Ratios
Profit as % of Revenues
25.2%
Profits as % of Assets
13.3%
Profits as % of Stockholder Equity
109.8%
Lists ranking Eli Lilly
